Advertisement

ADVERTISEMENT

testing guidelines

News
NCCN Biomarker Guideline Adherence Linked With Decreased Mortality in NSCLC
06/16/2020
Adherence to the National Comprehensive Cancer Network (NCCN) guideline for biomarker testing for non-squamous advanced non-small cell lung cancer (NSCLC) is associated with decreased risk of mortality, according to a recent...
Adherence to the National Comprehensive Cancer Network (NCCN) guideline for biomarker testing for non-squamous advanced non-small cell lung cancer (NSCLC) is associated with decreased risk of mortality, according to a recent...
Adherence to the National...
06/16/2020
Journal of Clinical Pathways
Consensus Recommendations for Germline Testing in Prostate Cancer
Guideline Updates
Consensus Recommendations for Germline Testing in Prostate Cancer
06/15/2020
A session entitled “Implementation of Germline Testing for Prostate Cancer” held at the Philadelphia Prostate Cancer Consensus Conference in 2019 provided novel recommendations for genetic testing. Germline testing...
A session entitled “Implementation of Germline Testing for Prostate Cancer” held at the Philadelphia Prostate Cancer Consensus Conference in 2019 provided novel recommendations for genetic testing. Germline testing...
A...
06/15/2020
Journal of Clinical Pathways
Research in Review
Predicting Survival, Treatment Response in Patients With Follicular Lymphoma
08/14/2017
JCP Editors
A recent study suggests a variable that should be used as a standard outcome measure for clinical trials of patients with follicular lymphoma, published in the British Journal of Hematology (online August 7, 2017;...
A recent study suggests a variable that should be used as a standard outcome measure for clinical trials of patients with follicular lymphoma, published in the British Journal of Hematology (online August 7, 2017;...
A...
08/14/2017
Journal of Clinical Pathways
Research in Review
NSCLC Prognostic Index Considers Personal Characteristics to Better Predict Outcomes
07/26/2017
JCP Editors
The Lung Cancer Prognostic Index provides personalized and disease-specific prognostic information for patients with non-small cell lung cancer (NSCLC) and may result in better survival outcomes, according to a...
The Lung Cancer Prognostic Index provides personalized and disease-specific prognostic information for patients with non-small cell lung cancer (NSCLC) and may result in better survival outcomes, according to a...
The...
07/26/2017
Journal of Clinical Pathways
Research in Review
Blood Test Predicts Survival Outcomes in Patients With Type of Lung Cancer
07/11/2017
JCP Editors
A blood-based proteomic test offers prognostic information and optimal second-line treatment guidance for patients with squamous cell carcinoma (SCC) of the lung, according to research published in Lung Cancer (July...
A blood-based proteomic test offers prognostic information and optimal second-line treatment guidance for patients with squamous cell carcinoma (SCC) of the lung, according to research published in Lung Cancer (July...
A...
07/11/2017
Journal of Clinical Pathways
Research in Review
Prognostic Tools Identify High-Risk Patients With Multiple Myeloma, Predict Survival
06/22/2017
JCP Editors
Multiple prognostic tools help risk stratify older patients with multiple myeloma and predict treatment-specific survival, according to data that will be presented at the 22nd Congress of the European Hematology...
Multiple prognostic tools help risk stratify older patients with multiple myeloma and predict treatment-specific survival, according to data that will be presented at the 22nd Congress of the European Hematology...
...
06/22/2017
Journal of Clinical Pathways
Research in Review
Recent Breast Cancer HER2 Testing Guideline Update Produces Similar Positivity Rate
06/14/2017
JCP Editors
Updates to the 2013 human epidermal growth factor receptor 2 (HER2) testing guideline in breast cancer did not affect the overall positivity rate or the proportion of patients eligible for targeted therapy, according...
Updates to the 2013 human epidermal growth factor receptor 2 (HER2) testing guideline in breast cancer did not affect the overall positivity rate or the proportion of patients eligible for targeted therapy, according...
...
06/14/2017
Journal of Clinical Pathways
Research in Review
Panel Highlights Uses of Genomic Testing for Breast Cancer
06/07/2017
JCP Editors
A panel of breast cancer experts offered an education session on the value of standard and genomic testing for breast cancer at the 2017 American Society of Clinical Oncology Annual Meeting (June 2-6, 2017; Chicago,...
A panel of breast cancer experts offered an education session on the value of standard and genomic testing for breast cancer at the 2017 American Society of Clinical Oncology Annual Meeting (June 2-6, 2017; Chicago,...
A...
06/07/2017
Journal of Clinical Pathways
Research in Review
Metastatic Breast Cancer Study Recruits Patients Via Social Media
06/04/2017
JCP Editors
A direct-to-patient approach has allowed the Metastatic Breast Cancer Project (MCBP) research study to identify nearly 3000 patients willing to provide medical records and tumor samples for analysis, according to...
A direct-to-patient approach has allowed the Metastatic Breast Cancer Project (MCBP) research study to identify nearly 3000 patients willing to provide medical records and tumor samples for analysis, according to...
A...
06/04/2017
Journal of Clinical Pathways
Research in Review
New NGS Platform Better Identifies Targetable Genomic Alterations in Metastatic Cancers
05/31/2017
JCP Editors
A new comprehensive next generation sequencing (NGS) platform is more likely than targeted NGS platforms to identify clinically relevant and actionable molecular alterations in metastatic cancers, according to...
A new comprehensive next generation sequencing (NGS) platform is more likely than targeted NGS platforms to identify clinically relevant and actionable molecular alterations in metastatic cancers, according to...
A new...
05/31/2017
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

Psych Congress Regionals
July 18 ⁠–⁠ July 19
Advances in Inflammatory Bowel Disease Regionals
July 19 ⁠–⁠ July 20
July 24 ⁠–⁠ July 26
APP Institute Inflammatory Bowel Disease
July 26 ⁠–⁠ July 27
July 27 ⁠–⁠ July 28
July 27 ⁠–⁠ July 28
Psych Congress Regionals
August 8 ⁠–⁠ August 9
August 14 ⁠–⁠ August 17
APP Institute Dermatology
August 16 ⁠–⁠ August 17
August 16 ⁠–⁠ August 18
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use